Kisspeptin-10: Mechanism of Action

Introduction

Kisspeptin-10 (KP-10) is a decapeptide agonist at the kisspeptin receptor (KISS1R), a class A G-protein-coupled receptor. The mechanism by which KP-10 activates KISS1R and the downstream intracellular signaling cascade that culminates in gonadotropin-releasing hormone (GnRH) secretion has been characterized in detail across published preclinical and clinical literature. This article describes the reported molecular interactions and downstream signaling events based on primary peer-reviewed research.

Receptor Target and Pathway

KISS1R (Gene ID: KISS1R; formerly GPR54) is the sole known receptor for kisspeptin peptides, including KP-10. The receptor is a seven-transmembrane domain G-protein-coupled receptor that couples preferentially to the heterotrimeric G-protein Gq/11, as characterized by Kotani and colleagues in 2001 [1] and subsequently confirmed by the International Union of Basic and Clinical Pharmacology in its formal 2010 nomenclature review [2].

KP-10 binds KISS1R with high affinity. The IUPHAR review reported that all kisspeptin isoforms — KP-54, KP-14, KP-13, and KP-10 — share equivalent receptor binding efficacy at KISS1R, consistent with structural data identifying the C-terminal decapeptide as the binding pharmacophore [2]. The C-terminal arginine-phenylalanine amide motif (Arg-Phe-NH₂), characteristic of the broader RF-amide neuropeptide family to which KP-10 belongs, constitutes a key pharmacophoric element for receptor engagement.

KISS1R expression in the context of reproductive neuroendocrinology is concentrated on GnRH neurons in the hypothalamus. Immunohistochemical and in situ hybridization studies documented GPR54 transcript co-localization with GnRH neurons in the mouse hypothalamus, providing an anatomical basis for direct kisspeptin actions on these neurons [3].

Reported Molecular Interactions

Upon KP-10 binding, KISS1R activates Gq/11, which in turn activates phospholipase C beta (PLCβ). PLCβ hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP₂) to generate two second messengers: inositol 1,4,5-trisphosphate (IP₃) and diacylglycerol (DAG). This canonical Gq signaling sequence has been reported consistently across multiple research models and was reviewed in detail by Colledge in 2009 [4].

IP₃ acts on IP₃ receptors on the endoplasmic reticulum, triggering release of Ca²⁺ from intracellular stores. DAG activates protein kinase C (PKC), which in turn phosphorylates downstream targets including mitogen-activated protein kinases ERK1/2 and p38, as described in mechanistic studies [5].

A study by Pielecka-Fortuna and colleagues reported that KP-10 activates transient receptor potential canonical (TRPC) channels in GnRH neurons through a mechanism requiring PIP₂ depletion and cSrc tyrosine kinase activation [5]. This represents a reported non-canonical branch of KISS1R signaling that contributes to GnRH neuron membrane depolarization. The same study reported that KP-10 simultaneously inhibits A-type potassium channels (Kv) and inwardly rectifying potassium channels (Kir), reducing outward K⁺ current and further contributing to sustained membrane depolarization.

The combined effect — TRPC channel opening, K⁺ channel inhibition, and Ca²⁺ mobilization — was reported to produce a prolonged depolarization of GnRH neurons and a sustained increase in action potential firing frequency [5]. Xu and colleagues, in a 2018 study published in Endocrinology, reported that this depolarization arises from a PLCβ/calcium-dependent pathway regulating multiple ion channels in concert, adding mechanistic resolution to the earlier Pielecka-Fortuna findings [6].

Downstream Effects

The downstream consequence reported in published preclinical and clinical literature is GnRH secretion from GnRH neuron terminals at the median eminence. Irwig and colleagues demonstrated in 2004 that kisspeptin could stimulate GnRH release directly at nerve terminals, using a preparation of isolated GnRH neurosecretory terminals — a finding significant because it identified a presynaptic locus of action in addition to the GnRH neuron soma [7].

In rat models, central kisspeptin administration was associated with GnRH release into cerebrospinal fluid and a parallel rise in serum luteinizing hormone (LH), documented in early pharmacological characterization studies [3]. Because GnRH is released into the hypophysial portal circulation and stimulates LH and FSH secretion from the anterior pituitary, LH measurement in plasma serves as an indirect functional readout of GnRH neuron activation in research studies.

The role of KP-10 in hypothalamic pulse generation has been examined in relation to the KNDy neuron population — arcuate nucleus neurons co-expressing kisspeptin, neurokinin B, and dynorphin A. The experimental evidence supporting this model is reviewed in detail in the published research article. Published models of GnRH pulse generation, reviewed in detail by Lehman and colleagues, propose that KNDy neurons function as a pulse generator in which kisspeptin signals to GnRH neurons at the output stage [8]. KP-10 experimental administration has been used in research to probe this pulse-generator circuitry by acute activation of KISS1R at GnRH neurons, making it a pharmacological tool for investigating HPG axis timing.

Active Research Frontiers

Several aspects of KISS1R signaling are under active investigation, representing productive areas for ongoing and future research. The relative contributions of central (hypothalamic) versus peripheral KISS1R populations to systemic GnRH and gonadotropin responses following systemic kisspeptin administration continue to be refined. Studies comparing central and peripheral administration routes in rodents reported that central administration elicits c-Fos expression in GnRH neurons whereas peripheral administration does not — an observation interpreted as consistent with KP-10 acting at GnRH nerve terminals in the median eminence rather than at the soma, a distinction with implications for analog design [3].

The rapid plasma clearance of kisspeptin-10 — with an estimated plasma half-life of approximately four minutes in rat pharmacokinetic studies [9] — has informed research into modified analogs with extended bioactivity. Quantitative characterization of receptor desensitization and internalization kinetics following continuous KP-10 exposure represents an active area, as understanding these dynamics is central to interpreting sustained-infusion experiments.

Additionally, while the Gq/11–PLCβ pathway is the best-characterized signaling axis downstream of KISS1R, published reports of additional coupling to Gi and G12/13 proteins in heterologous expression systems [2] open the possibility of context-dependent signaling diversity in native GnRH neuron populations — a question that current investigation is working to resolve. Comparative GPCR signaling patterns in related hypothalamic neuropeptide systems, including oxytocin acetate, have been similarly examined for context-dependent coupling variation.

References

1. Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le Poul E, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem. 2001;276(37):34631-34636. PMID: 11457843. DOI: 10.1074/jbc.M104847200

2. Pinilla L, Aguilar E, Dieguez C, Millar RP, Tena-Sempere M. Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol Rev. 2012;92(3):1235-1316. PMID: 22811428. DOI: 10.1152/physrev.00037.2010

3. Smith JT, Cunningham MJ, Rissman EF, Clifton DK, Steiner RA. Regulation of Kiss1 gene expression in the brain of the female mouse. Endocrinology. 2005;146(9):3686-3692. PMID: 15919743. DOI: 10.1210/en.2005-0488

4. Colledge WH. Kisspeptins and GnRH neuronal signalling. Trends Endocrinol Metab. 2009;20(3):115-121. PMID: 19272794. DOI: 10.1016/j.tem.2008.10.005

5. Pielecka-Fortuna J, Moenter SM. Kisspeptin activation of TRPC4 channels in female GnRH neurons requires PIP2 depletion and cSrc kinase activation. Endocrinology. 2012;153(6):2577-2588. PMID: 22518060. DOI: 10.1210/en.2011-1905

6. Xu C, Roepke TA, Zhang C, Kelly MJ, Rønnekleiv OK. Kisspeptin excites gonadotropin-releasing hormone (GnRH) neurons through a phospholipase C/calcium-dependent pathway regulating multiple ion channels. Endocrinology. 2018;159(9):3265-3279. PMID: 30016398. DOI: 10.1210/en.2018-00315

7. Irwig MS, Fraley GS, Smith JT, Acohido BV, Popa SM, Cunningham MJ, et al. Kisspeptin activation of gonadotropin releasing hormone neurons and regulation of KiSS-1 mRNA in the male rat. Neuroendocrinology. 2004;80(4):264-272. PMID: 15665093. DOI: 10.1159/000083140

8. Lehman MN, Coolen LM, Goodman RL. Minireview: kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion. Endocrinology. 2010;151(8):3479-3489. PMID: 20501670. DOI: 10.1210/en.2010-0022

9. Liu Z, Ren C, Jones W, Chen P, Seminara SB, Chan YM, et al. LC-MS/MS quantification of a neuropeptide fragment kisspeptin-10 (NSC 741805) and characterization of its decomposition product and pharmacokinetics in rats. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;926:1-8. PMID: 23524040. DOI: 10.1016/j.jchromb.2013.02.027